Andrew Gillman

The Melbourne epidemic thunderstorm asthma event 2016: an investigation of environmental triggers, effect on health services, and patient risk factors

Francis Thien, Paul J. Beggs, Danny Csutoros et al. · The Lancet Planetary Health · 2018 · 269 citations · Full text

Public Health, Emergency Medicine, Preventive Medicine +17

Mepolizumab effectiveness and identification of super-responders in severe asthma

David Langton, Constance H. Katelaris, Sean Stevens et al. · European Respiratory Journal · 2020 · 193 citations · Full text

Life Sciences, Internal Medicine, Pharmacotherapy +16

Clinical Efficacy and Immunologic Effects of Omalizumab in Allergic Bronchopulmonary Aspergillosis

Astrid Voskamp, Andrew Gillman, Karen Symons et al. · The Journal of Allergy and Clinical Immunology In Practice · 2015 · 182 citations

Life Sciences, Immunology, Pharmacotherapy +16

Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients

Dennis Thomas, Vanessa M. McDonald, Sean Stevens et al. · Allergy · 2023 · 87 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry

Peter G. Gibson, Helen K. Reddel, Vanessa M. McDonald et al. · Internal Medicine Journal · 2016 · 83 citations

Pharmacy, Pharmacology, Pharmacotherapy +17